Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| TransMedics Group, Inc.TMDX · Entity 4261 | Chief Financial Officer | June 03, 2024 | June 05, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
TransMedics Group, Inc.
Report date June 03, 2024 · Filed June 05, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 21,299 |
Ending reported balance
After 2024-06-03 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2024-06-03 · Exercise / conversion · Acquired 2,060 · Balance 23,359 F1: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 14, 2023. Row 2 · 2024-06-03 · Sale · Disposed 2,060 · Balance 21,299 F1: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 14, 2023. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $38.46 · Expires 2031-02-24 | Direct | 15,417 |
Reported balance
After 2024-06-03 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2024-06-03 · Exercise / conversion · Disposed 2,060 · Balance 15,417 F1: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 14, 2023. F2: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 24, 2025. |
Filing footnotes · ownership attribution and instrument terms
F1: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 14, 2023.
F2: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 24, 2025.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 03, 2024 Filed Jun 5, 2024 21:12 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,060 | $0.00 Strike: $38.46 | $0.00 |
DisclosureSEC source: 0000950170-24-069424 · ownership.xml · derivative · entry 3 Gordon Stephen · CIK 0001774274 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,417 Underlying: Common Stock · 2,060 shares Expires 2031-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 14, 2023. F2 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 24, 2025. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 21:12 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 2,060 | $135.93 | $280,015.80 |
DisclosureSEC source: 0000950170-24-069424 · ownership.xml · nonDerivative · entry 2 Gordon Stephen · CIK 0001774274 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 21,299 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 14, 2023. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 21:12 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 2,060 | $38.46 | $79,227.60 |
DisclosureSEC source: 0000950170-24-069424 · ownership.xml · nonDerivative · entry 1 Gordon Stephen · CIK 0001774274 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 23,359 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 14, 2023. Read SEC document |
| May 29, 2024 Filed May 31, 2024 20:30 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $66.10 | $0.00 |
DisclosureSEC source: 0000950170-24-067358 · ownership.xml · derivative · entry 13 Gordon Stephen · CIK 0001774274 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,022 Underlying: Common Stock · 5,000 shares Expires 2033-02-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 20, 2027. Read SEC document |
| May 29, 2024 Filed May 31, 2024 20:30 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $83.14 | $0.00 |
DisclosureSEC source: 0000950170-24-067358 · ownership.xml · derivative · entry 12 Gordon Stephen · CIK 0001774274 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,690 Underlying: Common Stock · 1,000 shares Expires 2034-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 23, 2028. Read SEC document |
| May 29, 2024 Filed May 31, 2024 20:30 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $13.28 | $0.00 |
DisclosureSEC source: 0000950170-24-067358 · ownership.xml · derivative · entry 11 Gordon Stephen · CIK 0001774274 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,167 Underlying: Common Stock · 5,000 shares Expires 2032-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 22, 2026. Read SEC document |
| May 29, 2024 Filed May 31, 2024 20:30 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $38.46 | $0.00 |
DisclosureSEC source: 0000950170-24-067358 · ownership.xml · derivative · entry 10 Gordon Stephen · CIK 0001774274 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,477 Underlying: Common Stock · 5,000 shares Expires 2031-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 24, 2025. Read SEC document |
| May 29, 2024 Filed May 31, 2024 20:30 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,000 | $0.00 Strike: $16.14 | $0.00 |
DisclosureSEC source: 0000950170-24-067358 · ownership.xml · derivative · entry 9 Gordon Stephen · CIK 0001774274 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84 Underlying: Common Stock · 2,000 shares Expires 2030-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option is fully vested. Read SEC document |
| May 29, 2024 Filed May 31, 2024 20:30 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 8,655 | $141.80 | $1,227,279.00 |
DisclosureSEC source: 0000950170-24-067358 · ownership.xml · nonDerivative · entry 8 Gordon Stephen · CIK 0001774274 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,299 F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $141.45 to $142.37, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| May 29, 2024 Filed May 31, 2024 20:30 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 9,345 | $141.06 | $1,318,205.70 |
DisclosureSEC source: 0000950170-24-067358 · ownership.xml · nonDerivative · entry 7 Gordon Stephen · CIK 0001774274 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,954 F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $140.445 to $141.44, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| May 29, 2024 Filed May 31, 2024 20:30 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 5,000 | $66.10 | $330,500.00 |
DisclosureSEC source: 0000950170-24-067358 · ownership.xml · nonDerivative · entry 6 Gordon Stephen · CIK 0001774274 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,299 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 29, 2024 Filed May 31, 2024 20:30 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 1,000 | $83.14 | $83,140.00 |
DisclosureSEC source: 0000950170-24-067358 · ownership.xml · nonDerivative · entry 5 Gordon Stephen · CIK 0001774274 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,299 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 29, 2024 Filed May 31, 2024 20:30 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 5,000 | $13.28 | $66,400.00 |
DisclosureSEC source: 0000950170-24-067358 · ownership.xml · nonDerivative · entry 4 Gordon Stephen · CIK 0001774274 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,299 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 29, 2024 Filed May 31, 2024 20:30 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 5,000 | $38.46 | $192,300.00 |
DisclosureSEC source: 0000950170-24-067358 · ownership.xml · nonDerivative · entry 3 Gordon Stephen · CIK 0001774274 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,299 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 29, 2024 Filed May 31, 2024 20:30 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 2,000 | $16.14 | $32,280.00 |
DisclosureSEC source: 0000950170-24-067358 · ownership.xml · nonDerivative · entry 2 Gordon Stephen · CIK 0001774274 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,299 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 29, 2024 Filed May 31, 2024 20:30 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 2,000 | $141.27 | $282,540.00 |
DisclosureSEC source: 0000950170-24-067358 · ownership.xml · nonDerivative · entry 1 Gordon Stephen · CIK 0001774274 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,299 F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $140.75 to $141.4025, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| May 06, 2024 Filed May 8, 2024 20:33 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $38.46 | $0.00 |
DisclosureSEC source: 0000950170-24-055800 · ownership.xml · derivative · entry 3 Gordon Stephen · CIK 0001774274 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 22,477 Underlying: Common Stock · 15,000 shares Expires 2031-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 14, 2023. F2 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 24, 2025. Read SEC document |
| May 06, 2024 Filed May 8, 2024 20:33 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 15,000 | $128.00 | $1,920,000.00 |
DisclosureSEC source: 0000950170-24-055800 · ownership.xml · nonDerivative · entry 2 Gordon Stephen · CIK 0001774274 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 23,299 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 14, 2023. Read SEC document |
| May 06, 2024 Filed May 8, 2024 20:33 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 15,000 | $38.46 | $576,900.00 |
DisclosureSEC source: 0000950170-24-055800 · ownership.xml · nonDerivative · entry 1 Gordon Stephen · CIK 0001774274 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 38,299 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 14, 2023. Read SEC document |
| April 01, 2024 Filed Apr 2, 2024 21:28 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $38.46 | $0.00 |
DisclosureSEC source: 0000950170-24-040393 · ownership.xml · derivative · entry 3 Gordon Stephen · CIK 0001774274 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 37,477 Underlying: Common Stock · 15,000 shares Expires 2031-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 14, 2023. F2 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 24, 2025. Read SEC document |
| April 01, 2024 Filed Apr 2, 2024 21:28 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 15,000 | $74.01 | $1,110,150.00 |
DisclosureSEC source: 0000950170-24-040393 · ownership.xml · nonDerivative · entry 2 Gordon Stephen · CIK 0001774274 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 23,299 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 14, 2023. Read SEC document |
| April 01, 2024 Filed Apr 2, 2024 21:28 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 15,000 | $38.46 | $576,900.00 |
DisclosureSEC source: 0000950170-24-040393 · ownership.xml · nonDerivative · entry 1 Gordon Stephen · CIK 0001774274 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 38,299 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 14, 2023. Read SEC document |
| March 08, 2024 Filed Mar 12, 2024 23:28 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 1,903 | $87.63 | $166,759.89 |
DisclosureSEC source: 0000950170-24-030275 · ownership.xml · nonDerivative · entry 1 Gordon Stephen · CIK 0001774274 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,299 F1 · kind: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction pursuant to the terms of the RSU award. Read SEC document |
| March 04, 2024 Filed Mar 5, 2024 23:20 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $38.46 | $0.00 |
DisclosureSEC source: 0000950170-24-026478 · ownership.xml · derivative · entry 3 Gordon Stephen · CIK 0001774274 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 52,477 Underlying: Common Stock · 15,000 shares Expires 2031-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 14, 2023. F2 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 24, 2025. Read SEC document |
| March 04, 2024 Filed Mar 5, 2024 23:20 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 15,000 | $82.80 | $1,242,000.00 |
DisclosureSEC source: 0000950170-24-026478 · ownership.xml · nonDerivative · entry 2 Gordon Stephen · CIK 0001774274 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 25,202 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 14, 2023. Read SEC document |
| March 04, 2024 Filed Mar 5, 2024 23:20 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 15,000 | $38.46 | $576,900.00 |
DisclosureSEC source: 0000950170-24-026478 · ownership.xml · nonDerivative · entry 1 Gordon Stephen · CIK 0001774274 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 40,202 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 14, 2023. Read SEC document |
| February 23, 2024 Filed Feb 27, 2024 22:00 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | GrantStock Option (Right to Buy) · Derivative | 18,690 | $0.00 Strike: $83.14 | $0.00 |
DisclosureSEC source: 0000950170-24-021334 · ownership.xml · derivative · entry 2 Gordon Stephen · CIK 0001774274 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,690 Underlying: Common Stock · 18,690 shares Expires 2034-02-23 F2 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares subject to the option each month following February 23, 2024 until the option is fully vested on February 23, 2028, subject to continued service. Read SEC document |
| February 23, 2024 Filed Feb 27, 2024 22:00 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | GrantCommon Stock | 12,127 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-021334 · ownership.xml · nonDerivative · entry 1 Gordon Stephen · CIK 0001774274 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,202 F1 · shares: Consists of 12,127 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| February 01, 2024 Filed Feb 2, 2024 23:56 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,523 | $0.00 Strike: $38.46 | $0.00 |
DisclosureSEC source: 0000950170-24-010796 · ownership.xml · derivative · entry 7 Gordon Stephen · CIK 0001774274 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 67,477 Underlying: Common Stock · 2,523 shares Expires 2031-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 14, 2023. F5 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 24, 2025. Read SEC document |
| February 01, 2024 Filed Feb 2, 2024 23:56 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,644 | $0.00 Strike: $16.14 | $0.00 |
DisclosureSEC source: 0000950170-24-010796 · ownership.xml · derivative · entry 6 Gordon Stephen · CIK 0001774274 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,084 Underlying: Common Stock · 3,644 shares Expires 2030-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 14, 2023. F4 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 27, 2024. Read SEC document |
| February 01, 2024 Filed Feb 2, 2024 23:56 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 8,833 | $0.00 Strike: $13.28 | $0.00 |
DisclosureSEC source: 0000950170-24-010796 · ownership.xml · derivative · entry 5 Gordon Stephen · CIK 0001774274 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 28,167 Underlying: Common Stock · 8,833 shares Expires 2032-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 14, 2023. F3 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 22, 2026. Read SEC document |
| February 01, 2024 Filed Feb 2, 2024 23:56 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 15,000 | $85.45 | $1,281,750.00 |
DisclosureSEC source: 0000950170-24-010796 · ownership.xml · nonDerivative · entry 4 Gordon Stephen · CIK 0001774274 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 13,075 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 14, 2023. F2 · balance_after: Includes 13,075 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| February 01, 2024 Filed Feb 2, 2024 23:56 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 2,523 | $38.46 | $97,034.58 |
DisclosureSEC source: 0000950170-24-010796 · ownership.xml · nonDerivative · entry 3 Gordon Stephen · CIK 0001774274 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 28,075 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 14, 2023. Read SEC document |
| February 01, 2024 Filed Feb 2, 2024 23:56 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 3,644 | $16.14 | $58,814.16 |
DisclosureSEC source: 0000950170-24-010796 · ownership.xml · nonDerivative · entry 2 Gordon Stephen · CIK 0001774274 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 25,552 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 14, 2023. Read SEC document |
| February 01, 2024 Filed Feb 2, 2024 23:56 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 8,833 | $13.28 | $117,302.24 |
DisclosureSEC source: 0000950170-24-010796 · ownership.xml · nonDerivative · entry 1 Gordon Stephen · CIK 0001774274 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 21,908 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 14, 2023. Read SEC document |
| January 02, 2024 Filed Jan 3, 2024 22:00 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $13.28 | $0.00 |
DisclosureSEC source: 0000950170-24-001054 · ownership.xml · derivative · entry 3 Gordon Stephen · CIK 0001774274 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 37,000 Underlying: Common Stock · 15,000 shares Expires 2032-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on December 16, 2022. F3 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 22, 2026. Read SEC document |
| January 02, 2024 Filed Jan 3, 2024 22:00 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 15,000 | $77.07 | $1,156,050.00 |
DisclosureSEC source: 0000950170-24-001054 · ownership.xml · nonDerivative · entry 2 Gordon Stephen · CIK 0001774274 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 13,075 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on December 16, 2022. F2 · balance_after: Includes 13,075 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| January 02, 2024 Filed Jan 3, 2024 22:00 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 15,000 | $13.28 | $199,200.00 |
DisclosureSEC source: 0000950170-24-001054 · ownership.xml · nonDerivative · entry 1 Gordon Stephen · CIK 0001774274 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 28,075 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on December 16, 2022. Read SEC document |
| November 17, 2023 Filed Nov 21, 2023 21:30 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | GiftCommon Stock | 5,714 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-23-065520 · ownership.xml · nonDerivative · entry 1 Gordon Stephen · CIK 0001774274 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,075 F1 · balance_after: Includes 13,075 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| October 02, 2023 Filed Oct 4, 2023 21:00 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $16.14 | $0.00 |
DisclosureSEC source: 0000950170-23-051960 · ownership.xml · derivative · entry 3 Gordon Stephen · CIK 0001774274 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,728 Underlying: Common Stock · 5,000 shares Expires 2030-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on December 16, 2022. F3 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 27, 2024. Read SEC document |
| October 02, 2023 Filed Oct 4, 2023 21:00 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 5,000 | $54.22 | $271,100.00 |
DisclosureSEC source: 0000950170-23-051960 · ownership.xml · nonDerivative · entry 2 Gordon Stephen · CIK 0001774274 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,789 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on December 16, 2022. F2 · balance_after: Includes 13,075 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| October 02, 2023 Filed Oct 4, 2023 21:00 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 5,000 | $16.14 | $80,700.00 |
DisclosureSEC source: 0000950170-23-051960 · ownership.xml · nonDerivative · entry 1 Gordon Stephen · CIK 0001774274 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,789 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on December 16, 2022. Read SEC document |
| May 01, 2023 Filed May 2, 2023 22:31 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $16.14 | $0.00 |
DisclosureSEC source: 0000899243-23-012010 · doc4.xml · derivative · entry 3 Gordon Stephen · CIK 0001774274 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,728 Underlying: Common Stock · 5,000 shares Expires 2030-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on December 16, 2022. F3 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 27, 2024. Read SEC document |
| May 01, 2023 Filed May 2, 2023 22:31 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 5,000 | $79.05 | $395,250.00 |
DisclosureSEC source: 0000899243-23-012010 · doc4.xml · nonDerivative · entry 2 Gordon Stephen · CIK 0001774274 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,789 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on December 16, 2022. F2 · balance_after: Includes 13,075 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| May 01, 2023 Filed May 2, 2023 22:31 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 5,000 | $16.14 | $80,700.00 |
DisclosureSEC source: 0000899243-23-012010 · doc4.xml · nonDerivative · entry 1 Gordon Stephen · CIK 0001774274 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,789 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on December 16, 2022. Read SEC document |
| March 01, 2023 Filed Mar 2, 2023 22:00 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $16.14 | $0.00 |
DisclosureSEC source: 0000899243-23-006758 · doc4.xml · derivative · entry 3 Gordon Stephen · CIK 0001774274 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,728 Underlying: Common Stock · 5,000 shares Expires 2030-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F3 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 27, 2024. Read SEC document |
| March 01, 2023 Filed Mar 2, 2023 22:00 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 5,000 | $79.51 | $397,550.00 |
DisclosureSEC source: 0000899243-23-006758 · doc4.xml · nonDerivative · entry 2 Gordon Stephen · CIK 0001774274 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,789 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · balance_after: Includes 13,075 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| March 01, 2023 Filed Mar 2, 2023 22:00 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 5,000 | $16.14 | $80,700.00 |
DisclosureSEC source: 0000899243-23-006758 · doc4.xml · nonDerivative · entry 1 Gordon Stephen · CIK 0001774274 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,789 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| February 20, 2023 Filed Feb 23, 2023 01:00 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | GrantStock Option (Right to Buy) · Derivative | 20,022 | $0.00 Strike: $66.10 | $0.00 |
DisclosureSEC source: 0000899243-23-005894 · doc4.xml · derivative · entry 2 Gordon Stephen · CIK 0001774274 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,022 Underlying: Common Stock · 20,022 shares Expires 2033-02-20 F2 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares subject to the option each month following February 20, 2023 until the option is fully vested on February 20, 2027, subject to continued service. Read SEC document |
| February 20, 2023 Filed Feb 23, 2023 01:00 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | GrantCommon Stock | 13,075 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-005894 · doc4.xml · nonDerivative · entry 1 Gordon Stephen · CIK 0001774274 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,789 F1 · shares: Includes 13,075 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.